These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 36808670)

  • 1. Evaluation of the efficacy of the hypocretin/orexin receptor agonists TAK-925 and ARN-776 in narcoleptic orexin/tTA; TetO-DTA mice.
    Sun Y; Ranjan A; Tisdale R; Ma SC; Park S; Haire M; Heu J; Morairty SR; Wang X; Rosenbaum DM; Williams NS; De Brabander JK; Kilduff TS
    J Sleep Res; 2023 Aug; 32(4):e13839. PubMed ID: 36808670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The development of sleep/wake disruption and cataplexy as hypocretin/orexin neurons degenerate in male vs. female Orexin/tTA; TetO-DTA Mice.
    Sun Y; Tisdale R; Park S; Ma SC; Heu J; Haire M; Allocca G; Yamanaka A; Morairty SR; Kilduff TS
    Sleep; 2022 Dec; 45(12):. PubMed ID: 35182424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TAK-994, a Novel Orally Available Brain-Penetrant Orexin 2 Receptor-Selective Agonist, Suppresses Fragmentation of Wakefulness and Cataplexy-Like Episodes in Mouse Models of Narcolepsy.
    Ishikawa T; Hara H; Kawano A; Tohyama K; Kajita Y; Miyanohana Y; Koike T; Kimura H
    J Pharmacol Exp Ther; 2023 Jun; 385(3):193-204. PubMed ID: 37001988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conditional ablation of orexin/hypocretin neurons: a new mouse model for the study of narcolepsy and orexin system function.
    Tabuchi S; Tsunematsu T; Black SW; Tominaga M; Maruyama M; Takagi K; Minokoshi Y; Sakurai T; Kilduff TS; Yamanaka A
    J Neurosci; 2014 May; 34(19):6495-509. PubMed ID: 24806676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GABAB agonism promotes sleep and reduces cataplexy in murine narcolepsy.
    Black SW; Morairty SR; Chen TM; Leung AK; Wisor JP; Yamanaka A; Kilduff TS
    J Neurosci; 2014 May; 34(19):6485-94. PubMed ID: 24806675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex-related differences within sleep-wake dynamics, cataplexy, and EEG fast-delta power in a narcolepsy mouse model.
    Piilgaard L; Rose L; Gylling Hviid C; Kohlmeier KA; Kornum BR
    Sleep; 2022 Jul; 45(7):. PubMed ID: 35266540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OX2R-selective orexin agonism is sufficient to ameliorate cataplexy and sleep/wake fragmentation without inducing drug-seeking behavior in mouse model of narcolepsy.
    Yamamoto H; Nagumo Y; Ishikawa Y; Irukayama-Tomobe Y; Namekawa Y; Nemoto T; Tanaka H; Takahashi G; Tokuda A; Saitoh T; Nagase H; Funato H; Yanagisawa M
    PLoS One; 2022; 17(7):e0271901. PubMed ID: 35867683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wake-promoting effects of ONO-4127Na, a prostaglandin DP1 receptor antagonist, in hypocretin/orexin deficient narcoleptic mice.
    Sagawa Y; Sato M; Sakai N; Chikahisa S; Chiba S; Maruyama T; Yamamoto J; Nishino S
    Neuropharmacology; 2016 Nov; 110(Pt A):268-276. PubMed ID: 27474349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonpeptide orexin type-2 receptor agonist ameliorates narcolepsy-cataplexy symptoms in mouse models.
    Irukayama-Tomobe Y; Ogawa Y; Tominaga H; Ishikawa Y; Hosokawa N; Ambai S; Kawabe Y; Uchida S; Nakajima R; Saitoh T; Kanda T; Vogt K; Sakurai T; Nagase H; Yanagisawa M
    Proc Natl Acad Sci U S A; 2017 May; 114(22):5731-5736. PubMed ID: 28507129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous intrathecal orexin delivery inhibits cataplexy in a murine model of narcolepsy.
    Kaushik MK; Aritake K; Imanishi A; Kanbayashi T; Ichikawa T; Shimizu T; Urade Y; Yanagisawa M
    Proc Natl Acad Sci U S A; 2018 Jun; 115(23):6046-6051. PubMed ID: 29784823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Running promotes wakefulness and increases cataplexy in orexin knockout mice.
    España RA; McCormack SL; Mochizuki T; Scammell TE
    Sleep; 2007 Nov; 30(11):1417-25. PubMed ID: 18041476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The orexin story, sleep and sleep disturbances.
    Pizza F; Barateau L; Dauvilliers Y; Plazzi G
    J Sleep Res; 2022 Aug; 31(4):e13665. PubMed ID: 35698789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orexin peptides prevent cataplexy and improve wakefulness in an orexin neuron-ablated model of narcolepsy in mice.
    Mieda M; Willie JT; Hara J; Sinton CM; Sakurai T; Yanagisawa M
    Proc Natl Acad Sci U S A; 2004 Mar; 101(13):4649-54. PubMed ID: 15070772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TAK-925, an orexin 2 receptor-selective agonist, shows robust wake-promoting effects in mice.
    Yukitake H; Fujimoto T; Ishikawa T; Suzuki A; Shimizu Y; Rikimaru K; Ito M; Suzuki M; Kimura H
    Pharmacol Biochem Behav; 2019 Dec; 187():172794. PubMed ID: 31654653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual orexin and MCH neuron-ablated mice display severe sleep attacks and cataplexy.
    Hung CJ; Ono D; Kilduff TS; Yamanaka A
    Elife; 2020 Apr; 9():. PubMed ID: 32314734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-invasive detection of narcolepsy type I phenotypical features and disease progression by continuous home-cage monitoring of activity in two mouse models: the HCRT-KO and DTA model.
    Piilgaard L; Rose L; Justinussen JL; Hviid CG; Lemcke R; Wellendorph P; Kornum BR
    Sleep; 2023 Sep; 46(9):. PubMed ID: 37210587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward the Mysteries of Sleep.
    Yanagisawa M
    Keio J Med; 2019; 68(1):27. PubMed ID: 30905886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of inhibitory serotonergic inputs to orexin/hypocretin neurons on the diurnal rhythm of sleep and wakefulness.
    Tabuchi S; Tsunematsu T; Kilduff TS; Sugio S; Xu M; Tanaka KF; Takahashi S; Tominaga M; Yamanaka A
    Sleep; 2013 Sep; 36(9):1391-404. PubMed ID: 23997373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Almorexant promotes sleep and exacerbates cataplexy in a murine model of narcolepsy.
    Black SW; Morairty SR; Fisher SP; Chen TM; Warrier DR; Kilduff TS
    Sleep; 2013 Mar; 36(3):325-36. PubMed ID: 23449602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of narcolepsy-like symptoms by orexin receptor antagonists in mice.
    Kaushik MK; Aritake K; Cherasse Y; Imanishi A; Kanbayashi T; Urade Y; Yanagisawa M
    Sleep; 2021 Aug; 44(8):. PubMed ID: 33609365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.